Search research articles
Contact Us
Filters
Showing results (191-200 of 272) with videos related to
Page
of 28
Sort By:
The Lancet Regional Health. Europe
|
May 30, 2024
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
Clinical and Translational Medicine
|
June 23, 2025
Programmed death-ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV-2 translational study
Francesca Basso-Valentina, Vincenzo Canzonieri, Rossella De Cecio, et al.
Plos One
|
August 6, 2010
Time spent for activation of non-profit studies in oncology in Italy
Gianfranco De Feo, Simona Signoriello, Jane C Bryce, et al.
The Lancet Regional Health. Europe
|
October 24, 2024
Withdrawal notice to <Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]>
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
The Lancet Regional Health. Europe
|
April 26, 2024
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
Contemporary Clinical Trials
|
October 8, 2020
TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol
Maria Carmela Piccirillo, Paolo Ascierto, Luigi Atripaldi, et al.
BMC Cancer
|
August 3, 2006
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial
Sandro Pignata, Giovanni Scambia, Antonella Savarese, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 28, 2011
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial
Cesare Gridelli, Ciro Gallo, Alessandro Morabito, et al.
Critical Reviews in Oncology/Hematology
|
December 28, 2007
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial
Francesco Nuzzo, Alessandro Morabito, Ermelinda De Maio, et al.
Endocrine
|
March 24, 2018
Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study
Maria Grazia Chiofalo, Simona Signoriello, Franco Fulciniti, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 272) with videos related to
Sort By:
Page
of 28
The Lancet Regional Health. Europe
|
May 30, 2024
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
Clinical and Translational Medicine
|
June 23, 2025
Programmed death-ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV-2 translational study
Francesca Basso-Valentina, Vincenzo Canzonieri, Rossella De Cecio, et al.
Plos One
|
August 6, 2010
Time spent for activation of non-profit studies in oncology in Italy
Gianfranco De Feo, Simona Signoriello, Jane C Bryce, et al.
The Lancet Regional Health. Europe
|
October 24, 2024
Withdrawal notice to <Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]>
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
The Lancet Regional Health. Europe
|
April 26, 2024
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
Contemporary Clinical Trials
|
October 8, 2020
TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol
Maria Carmela Piccirillo, Paolo Ascierto, Luigi Atripaldi, et al.
BMC Cancer
|
August 3, 2006
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial
Sandro Pignata, Giovanni Scambia, Antonella Savarese, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 28, 2011
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial
Cesare Gridelli, Ciro Gallo, Alessandro Morabito, et al.
Critical Reviews in Oncology/Hematology
|
December 28, 2007
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial
Francesco Nuzzo, Alessandro Morabito, Ermelinda De Maio, et al.
Endocrine
|
March 24, 2018
Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study
Maria Grazia Chiofalo, Simona Signoriello, Franco Fulciniti, et al.
Page
of 28